The technology, which received FDA clearance in 2023, showed promising results in a ... which has provided many potential ...

Analysis of Pfizer's financial performance, acquisitions, and future prospects, highlighting key challenges and opportunities ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Then in October, the FDA expanded the approval of Pfizer's bivalent RSV prefusion F vaccine (Abrysvo) to include adults ages ...

STAT's Readout LOUD podcast discusses how Trump's second term and the MAHA movement could affect FDA regulation, the ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Moderna's Spikevax COVID vaccine brought in sales of $1.8 billion, up 3.5% over the previous year and handily beating analysts' average expectations of $1.38 billion. The company said it benefited ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.